These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2223395)

  • 41. Immuno-cell therapy of cancer in Japan.
    Egawa K
    Anticancer Res; 2004; 24(5C):3321-6. PubMed ID: 15515427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adoptive cellular therapy.
    Hoffman DM; Gitlitz BJ; Belldegrun A; Figlin RA
    Semin Oncol; 2000 Apr; 27(2):221-33. PubMed ID: 10768601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adoptive cellular immunotherapy of cancer: future perspectives.
    Stevenson HC
    Immunol Ser; 1989; 48():229-36. PubMed ID: 2488324
    [No Abstract]   [Full Text] [Related]  

  • 44. Autologous activated lymphocyte therapy in a community hospital.
    Horváth J; Szabó-Szabari M; Sinkovics JG
    Acta Microbiol Immunol Hung; 1994; 41(2):205-14. PubMed ID: 7804724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adoptive immunotherapy of renal cell carcinoma: studies from the Surgery Branch, National Cancer Institute.
    Linehan WM; Walther MM; Alexander RB; Rosenberg SA
    Semin Urol; 1993 Feb; 11(1):41-3. PubMed ID: 8465127
    [No Abstract]   [Full Text] [Related]  

  • 46. Adoptive cellular immunotherapy of cancer.
    Winter H; Fox BA
    Curr Opin Mol Ther; 1999 Feb; 1(1):89-97. PubMed ID: 11249690
    [No Abstract]   [Full Text] [Related]  

  • 47. Adoptive immunotherapy.
    Sznol M; Urba WJ
    Cancer Chemother Biol Response Modif; 1994; 15():213-25. PubMed ID: 7779587
    [No Abstract]   [Full Text] [Related]  

  • 48. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy.
    Yannelli JR; Wroblewski JM
    Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells].
    Osanto S; Brand A; van Rood JJ; Cleton FJ
    Ned Tijdschr Geneeskd; 1989 Jul; 133(28):1392-5. PubMed ID: 2677758
    [No Abstract]   [Full Text] [Related]  

  • 50. [Interleukin-2 immunotherapy and cutaneous manifestations].
    Larbre B; Nicolas JF; Sarret Y; Tognet E; Mercatello A; Thivolet J
    Ann Dermatol Venereol; 1993; 120(8):528-33. PubMed ID: 8304709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The clinical study of local treatment of ocular malignant tumors with IL-2 LAK cells].
    Yang L; Zhang J; Liang G
    Zhonghua Yan Ke Za Zhi; 1995 May; 31(3):215-7. PubMed ID: 7555407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dynamics of cytotoxicity of blood mononuclear cells in patients with bladder cancer during endolymphatic immunotherapy with lymphokine- activated killer cells and recombinant interleukin-2].
    Malakhova NV; Figurin KM; Fedorova NS; Kiselevskiĭ MV; Bykovskaia SN
    Biull Eksp Biol Med; 1996 Feb; 121(2):188-91. PubMed ID: 9026128
    [No Abstract]   [Full Text] [Related]  

  • 53. Tumor-derived activated cells: culture conditions and characterization.
    Maleckar JR; Friddell CS; Lewko WM; Yannelli JR; West WH; Oldham RK
    Immunol Ser; 1989; 48():159-73. PubMed ID: 2488319
    [No Abstract]   [Full Text] [Related]  

  • 54. Liver metastases from gastric carcinoma: report of a patient treated with adoptive immunotherapy (tumor-infiltrating lymphocytes plus interleukin-2 and subsequently local-regional lymphokine-activated killer cells plus interleukin-2).
    Fabbri L; Ridolfi R; Riccobon A; Maltoni R; Flamini E; Fedriga R; Flamigni A; Migliori G; Ortolani F; Calzolari F
    Tumori; 1995; 81(6):445-9. PubMed ID: 8804474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.
    Rosenberg SA
    J Clin Oncol; 1992 Feb; 10(2):180-99. PubMed ID: 1732421
    [No Abstract]   [Full Text] [Related]  

  • 56. [Adjuvant immunotherapy for lung cancer].
    Kawamura M
    Nihon Rinsho; 2002 May; 60 Suppl 5():459-62. PubMed ID: 12101714
    [No Abstract]   [Full Text] [Related]  

  • 57. Recombinant antibody fusion proteins for cancer immunotherapy.
    Reisfeld RA; Gillies SD
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():27-53. PubMed ID: 8815009
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report.
    Huang Y; Hayes RL; Wertheim S; Arbit E; Scheff R
    Crit Rev Oncol Hematol; 2001; 39(1-2):17-23. PubMed ID: 11418298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cellular adoptive immunotherapy after bone marrow transplantation.
    Riddell SR; Greenberg PD
    Cancer Treat Res; 1995; 76():337-69. PubMed ID: 7577343
    [No Abstract]   [Full Text] [Related]  

  • 60. Cellular immunotherapy: a new avenue in internal medicine.
    Toungouz M; Velu T; Thielemans K
    Acta Clin Belg; 1998 Feb; 53(1):9-18. PubMed ID: 9562700
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.